Currently, there are 7.18B common shares owned by the public and among those 7.17B shares have been available to trade.
The company’s stock has a 5-day price change of 5.42% and 16.79% over the past three months. T shares are trading 13.61% year to date (YTD), with the 12-month market performance up to 53.08% higher. It has a 12-month low price of $15.94 and touched a high of $25.74 over the same period. T has an average intraday trading volume of 36.38 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 7.41%, 10.94%, and 24.38% respectively.
Institutional ownership of AT&T, Inc (NYSE: T) shares accounts for 63.49% of the company’s 7.18B shares outstanding.
It has a market capitalization of $185.70B and a beta (3y monthly) value of 0.57. The stock’s trailing 12-month PE ratio is 17.34, while the earnings-per-share (ttm) stands at $1.49. The company has a PEG of 5.08 and a Quick Ratio of 0.62 with the debt-to-equity ratio at 1.35. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.40% over the week and 1.90% over the month.
Analysts forecast that AT&T, Inc (T) will achieve an EPS of 0.53 for the current quarter, 0.56 for the next quarter and 2.25 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.46 while analysts give the company a high EPS estimate of 0.46. Comparatively, EPS for the current quarter was 0.55 a year ago. Earnings per share for the fiscal year are expected to decrease by -7.65%, and 7.05% over the next financial year. EPS should grow at an annualized rate of 3.41% over the next five years, compared to -4.67% over the past 5-year period.
Looking at the support for the T, a number of firms have released research notes about the stock. Exane BNP Paribas stated their Outperform rating for the stock in a research note on February 13, 2025, with the firm’s price target at $28.50. DZ Bank coverage for the AT&T, Inc (T) stock in a research note released on January 29, 2025 offered a Buy rating with a price target of $27. Argus was of a view on January 16, 2025 that the stock is Buy, while RBC Capital Mkts gave the stock Outperform rating on January 06, 2025, issuing a price target of $22- $26. Morgan Stanley on their part issued Overweight rating on December 16, 2024.
